Ro 40-7592, a COMT inhibitor, plus levodopa in Parkinson's disease.
Limousin
P
P
Pollak
P
P
Gervason-Tournier
C L
CL
Hommel
M
M
Perret
J E
JE
D000368:Aged; D001577:Benzophenones / Q000493:pharmacokinetics / Q000627:therapeutic use*; D065098:Catechol O-Methyltransferase Inhibitors; D004311:Double-Blind Method; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007980:Levodopa / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D009596:Nitrophenols; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D000077867:Tolcapone
D001577:Benzophenones; D065098:Catechol O-Methyltransferase Inhibitors; D009596:Nitrophenols; D007980:Levodopa; D000077867:Tolcapone